Alkermes Plc (ALKS)
31.91
-0.09
(-0.28%)
USD |
NASDAQ |
Feb 20, 16:00
31.86
-0.05
(-0.16%)
After-Hours: 20:00
Alkermes Market Cap : 5.269B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Avadel Pharmaceuticals Plc | 2.124B |
| Krystal Biotech, Inc. | 7.592B |
| Assertio Holdings, Inc. | 75.97M |
| Amicus Therapeutics, Inc. | 4.499B |
| Jazz Pharmaceuticals Plc | 10.46B |
Market Cap Related Metrics
| PE Ratio | 15.79 |
| PS Ratio | 3.525 |
| PEG Ratio | 5.353 |
| Price to Book Value | 3.040 |
| Price to Free Cash Flow | 10.92 |
| Price | 31.91 |
| Earnings Yield | 6.33% |
| PEGY Ratio | 5.353 |
| Operating PE Ratio | 14.96 |
| Normalized PE Ratio | 15.76 |